Cargando…
Evaluation of the therapeutic efficacy of a MEK inhibitor (TAK-733) using (18)F-fluorodeoxyglucose-positron emission tomography in the human lung xenograft model A549
OBJECTIVE: The aim of this study was to evaluate the potential of (18)F-fluorodeoxyglucose-positron emission tomography ((18)F-FDG-PET) for monitoring the therapeutic efficacy of TAK-733, an inhibitor of mitogen-activated protein kinase kinase, in nude rats bearing A549 (human lung carcinoma) xenogr...
Autores principales: | Ishino, Seigo, Miyake, Hiroshi, Vincent, Patrick, Mori, Ikuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526591/ https://www.ncbi.nlm.nih.gov/pubmed/26014721 http://dx.doi.org/10.1007/s12149-015-0984-4 |
Ejemplares similares
-
Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts
por: Lieu, Christopher H., et al.
Publicado: (2015) -
Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009) -
Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020) -
Neurolymphomatosis detected by (18)F‐fluorodeoxyglucose‐positron emission tomography
por: Hori, Yoshikazu, et al.
Publicado: (2020) -
Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022)